In the United States, an estimated 17% of adolescents experienced at least 1 episode of major depression in the past year, and the rate among members of marginalized populations is believed to be significantly higher.
The Innovation and Value Initiative (IVI), a nonprofit research organization committed to advancing the science, practice, and use of value assessment in health care, today announced a collaboration with the University of Southern California Leonard D. Schaeffer Center for Health Policy & Economics to examine treatment patterns and disparities for children and young adults newly diagnosed with major depressive disorder (MDD).
In the United States, an estimated 17% of adolescents experienced at least 1 episode of major depression in the past year, and the rate among members of marginalized populations is believed to be significantly higher. The symptoms of childhood and adolescence depression can include academic decline, withdrawal, unexpected crying, weight changes, and thoughts or actions of self-harm. All too often, depression goes undiagnosed and untreated in this vulnerable population.
Bringing together health policy experts and a seasoned health economics and outcomes research (HEOR) team, this partnership will focus on:
“The USC Schaeffer Center partnership provides a meaningful opportunity to learn how COVID-19 and the broader access to telehealth services has affected health care outcomes and disparities,” noted Rick Chapman, PhD, chief science officer at IVI. “Our goal is to close the gaps and better inform health care outcomes for children and adolescents with major depressive disorder.”
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Understanding Primary and Secondary Nonadherence to Chronic Oral Medication
March 28th 2025Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new research conducted among patients and health care providers and presented by the American Medical Group Association at its 2025 annual meeting, held March 26-29 in Grapevine, Texas.
Read More